Case Report| Volume 16, ISSUE 12, P1631-1633, December 2009

Download started.


Very late thrombosis in a patient with a drug-eluting stent for intracranial atherosclerotic stenosis


      Late stent thrombosis is an infrequent, but severe, complication after implantation of a drug-eluting stent. We report one such patient, a 69-year-old man with intracranial vertebral artery stenosis. He experienced very late stent thrombosis after discontinuation of clopidogrel therapy, about 16 months after the insertion of a Taxus Stent® (Boston Scientific Corporation, Natick, MA, USA). The patient recovered well, with good clinical outcome, after the re-initiation of dual antiplatelet and anticoagulation therapy. No abnormality within the stent was identified on a repeat angiogram taken 4 weeks after treatment re-initiation.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Clinical Neuroscience
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Wong K.S.
        • Huang Y.N.
        • Yang H.B.
        • et al.
        A door-to-door survey of intracranial atherosclerosis in Liangbei County, China.
        Neurology. 2007; 69: 2031-2034
        • Jiang W.J.
        • Xu X.T.
        • Jin M.
        • et al.
        Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results.
        Am J Neuroradiol. 2007; 28: 830-834
        • The SSYLVIA study investigators
        Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results.
        Stroke. 2004; 35: 1388-1392
        • Qureshi A.I.
        • Kirmani J.F.
        • Hussein H.M.
        • et al.
        Early- and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis.
        Neurosurgery. 2006; 59: 1044-1051
        • Abou-Chebl A.
        • Bashir Q.
        • Yadav J.S.
        • et al.
        Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up.
        Stroke. 2005; 36: E165-E168
        • Jiang W.J.
        • Xu X.T.
        • Du B.
        • et al.
        Comparison of elective stenting of severe vs. moderate intracranial atherosclerotic stenosis.
        Neurology. 2007; 68: 420-426
        • Holmes Jr., D.R.
        • Leon M.B.
        • Moses J.W.
        • et al.
        Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.
        Circulation. 2004; 109: 634-640
        • Lee T.H.
        • Choi C.H.
        • Park K.P.
        • et al.
        Techniques for intracranial stent navigation in patients with tortuous vessels.
        Am J Neuroradiol. 2005; 26: 1375-1380
        • Iakavou I.
        • Schimdt T.
        • Bonizzoni E.
        • et al.
        Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents.
        JAMA. 2005; 293: 2126-2130
        • Eisenstein E.L.
        • Anstrom K.J.
        • Kong D.F.
        • et al.
        Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
        JAMA. 2007; 297: 159-168
        • Serruys P.W.
        • Daemen J.
        Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents.
        Circulation. 2007; 115: 1433-1439